Vergleich

CP-724714 Europäischer Partner

Hersteller Selleckchem
Kategorie
Typ Inhibitors
Specific against other
Menge 5 g
ArtNr S1167-5000
Targets ERBB2
CAS-Nr. 537705-08-1
eClass 6.1 30220300
eClass 9.0 32160605
Lieferbar
Administration
Administered via p.o.
Animal Models
FRE-erbB2 BT-474, MDA-MB-453, MDA-MB-231, LoVo (colon), and Colo-205 (colon) xenografts are established in athymic female mice (CD-1 nu/nu).
Cell lines
ZR-75-30, HCC-1419, MDA-MB-175, BT-474, SKBR3, MDA-MB-361, UACC-812, T-47D, MDA-MB-453, MDA-MB-468, CAMA-1, MDA-MB-157, MCF-7, MDA-MB-435, ZR-75-1, BT-20, and MDA-MB-231.
Chemical Name
(E)-2-methoxy-N-(3-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-6-yl)allyl)acetamide
Clinical Trials
Phase I is completed in patients with metastatic HER2-overexpressing breast cancer.
Concentrations
0.1 nM - 10 uM.
Description
CP-724, 714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM and also inhibits EGFR with IC50 of 6.4 uM.
Dosages
ca.100 mg/kg.
Formulation
0.5% methylcellulose.
IC50
10 nM, 10 nM, 10 nM, 10 nM, 10 nM, 10 nM
In vitro
CP-724, 714 is marked selectively against EGFR with IC50 of 6.4 uM. CP-724, 714 is >1, 000-fold less potent for IR, IGF-1R, PDGFRbeta, VGFR2, abl. Src, c-Met c-jun NH2-terminal kinase (JNK)-2, JNK-3, ZAP-70, cyclin-dependent kinase (CDK)-2, and CDK-5. CP-724, 714 potently reduces the EGF-induced autophosphorylation of the chimera containing the erbB2 kinase domain with IC50 of 32 nM, but is markedly less potent against EGFR in transfected NIH3T3 cells. CP-724, 714 sensitively inhibits the proliferation of erbB2-amplified cells including BT-474 and SKBR3, with IC50 of 0.25 and 0.95 uM. CP-724, 714 induces the accumulation of cells in G1 phase and a marked reduction in S-phase in BT-474 cells at 1 uM. [1] CP-724, 714 likely exerts its hepatotoxicity via both hepatocellular injury and hepatobiliary cholestatic mechanisms. CP-724, 714 displays inhibition of cholyl-lysyl fluorescein and taurocholate (TC) efflux into canaliculi in cryopreserved and fresh cultured human hepatocytes, respectively. CP-724, 714 inhibits TC transport in membrane vesicles expressing human bile salt export pump with IC50 of 16 uM and inhibits the major efflux transporter in bile canaliculi, MDR1, with IC50 of ca.28 uM. [2]
In vivo
CP-724, 714 (25 mg/kg) is rapidly absorbed after p.o. administration and causes reduction of tumor erbB2 receptor phosphorylation after dosing in FRE-erbB2 or BT-474 xenografts. CP-724, 714 induces apoptosis in FRE-erbB2 xenograft–bearing (s.c.) mice and shows 50% tumor growth inhibition at 50 mg/kg, without weight loss or mortality. CP-724, 714 also has great antitumor activity in MDA-MB-453, MDA-MB-231, LoVo (colon), and Colo-205 (colon) xenografts. Furthermore, CP-724, 714 (30 or 100 mg/kg) reduces the extracellular signal–regulated kinase and Akt phosphorylation in BT-474 xenografts. [1]
Incubation Time
6 to 7 days.
Kinase Assay
Kinase assays, Recombinant erbB2 (amino acid residues 675-1255) and EGFR (amino acid residues 668-1211) intracellular domains are expressed in baculovirus-infected Sf9 cells as glutathione S-transferase fusion proteins. The proteins are purified by affinity chromatography on glutathione Sepharose beads for use in the assay. Nunc MaxiSorp 96-well plates are coated by incubation overnight at 37 C with 100 uL/well of 0.25 mg/mL poly(Glu:Tyr, 4:1), PGT in PBS. Excess PGT is removed by aspiration and the plate is washed 3 times with wash buffer (0.1% Tween 20 in PBS). The kinase reaction is performed in 50 uL of 50 mm HEPES (pH 7.4) containing 125 mm sodium chloride, 10 mm magnesium chloride, 0.1 mm sodium orthovanadate, 1 mm ATP, and 15 ng of recombinant protein. Inhibitors in DMSO are added, the final DMSO concentration is 2.5%. Phosphorylation is initiated by addition of ATP and proceeded for 6 min at room temperature, with constant shaking. The kinase reaction is terminated by aspiration of the reaction mixture and washing four times with wash buffer. Phosphorylated PGT is measured after a 25-min incubation with 50 uL/well HRP conjugated-PY54 antiphosphotyrosine antibody, diluted to 0.2 ug/mL in blocking buffer (3% BSA, 0.05% Tween 20 in PBS). Antibody is removed by aspiration and the plate is washed four times with wash buffer. The colorimetric signal is developed by addition of 50 uL/well Tetramethylbenzidine Microwell Peroxidase Substrate and stopped by the addition of 50 uL/well 0.09 m sulfuric acid. The phosphotyrosine product formed is estimated by measurement of absorbance at 450 nm. The signal for controls is typically A0.6–1.2, with essentially no background in wells without ATP, kinase protein, or PGT, and is proportional to the time of incubation for 6 min.
Method
Cells are seeded in duplicate at 5ca.10 x 103 per well in 24-well plates. The day after plating, CP-724, 714 is added by titrating over six or more dilutions from 0.1 nM to 10 uM. Control wells without CP-724, 714 are seeded as well. Cells are grown for 6 to 7 days, at which time surviving cells are counted. After trypsinization, cells are placed in isotone solution and counted immediately using a Coulter Z2 particle counter. Growth inhibition is calculated [(1 experimental value / control value) x 100] for each concentration. Dose-response curves are repeated at least twice and averaged. IC50 values are calculated using Calcusyn Software.
Molecular Weight (MW)
469, 53
Picture ChemicalStructure Description
CP-724714 Chemical Structure
Picture Description 1
, , Reto Baumann from ETH Zurich, CP-724714purchased from Selleck, After starved in primary serum, rat Schwann cells was stimulated for 15 minutes with a soluble form of neuregulin 1 type III to activate ErbB2. Activity of ErbB2 was determined by phosphorylation on Tyr1248. CP-724714 was applied at different concentrations, but achieved strong RTK inhibition already at very low concentrations.
Picture Description 2
, , Dr. Yong-Weon Yi from Georgetown University Medical Center, CP-724714purchased from Selleck, For MTT assays, cells (2, 000 ca. 5, 000 cells/well) were subcultured into 96-well plates according to their growth properties. Cell proliferation was assayed at 72 hr after treatment of CP-724714 by adding 20 l of 5 mg/ml 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) solution per 100 l of growth medium. After incubating for 3-4 h at 37C, the media were removed and 150 l/well of MTT solvent (either absolute DMSO or isopropanol containing 4 M HCl and 0.1% Nonidet-40) was added to dissolve the formazan.
Solubility (25C)
DMSO 94 mg/mL, Water <1 mg/mL, Ethanol 94 mg/mL
Storage
2 years -20CPowder, 2 weeks4Cin DMSO, 2 months-80Cin DMSO

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 5 g
Lieferbar: In stock
lieferbar

Lieferung vsl. bis 06.06.2024 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen